IDE “Clinical Holds” Can Prompt Industry Request For FDA Rationale

A final guidance on so-called 517A requests, in which companies can request a substantive summary of FDA’s rationale for certain decisions, puts an agency halt of a device trial on the list of actions that qualify for such a request. That is a new addition from the 2013 draft version.